Menu
GWAS Study

Genetic factors define CPO and CLO subtypes of nonsyndromicorofacial cleft.

Huang L, Jia Z, Shi Y et al.

31609978 PubMed ID
GWAS Study Type
12363 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HL
Huang L
JZ
Jia Z
SY
Shi Y
DQ
Du Q
SJ
Shi J
WZ
Wang Z
MY
Mou Y
WQ
Wang Q
ZB
Zhang B
WQ
Wang Q
MS
Ma S
LH
Lin H
DS
Duan S
YB
Yin B
LY
Lin Y
WY
Wang Y
JD
Jiang D
HF
Hao F
ZL
Zhang L
WH
Wang H
JS
Jiang S
XH
Xu H
YC
Yang C
LC
Li C
LJ
Li J
SB
Shi B
YZ
Yang Z
Chapter II

Abstract

Summary of the research findings

Nonsyndromic orofacial cleft (NSOFC) is a severe birth defect that occurs early in embryonic development and includes the subtypes cleft palate only (CPO), cleft lip only (CLO) and cleft lip with cleft palate (CLP). Given a lack of specific genetic factor analysis for CPO and CLO, the present study aimed to dissect the landscape of genetic factors underlying the pathogenesis of these two subtypes using 6,986 cases and 10,165 controls. By combining a genome-wide association study (GWAS) for specific subtypes of CPO and CLO, as well as functional gene network and ontology pathway analysis, we identified 18 genes/loci that surpassed genome-wide significance (P < 5 × 10-8) responsible for NSOFC, including nine for CPO, seven for CLO, two for both conditions and four that contribute to the CLP subtype. Among these 18 genes/loci, 14 are novel and identified in this study and 12 contain developmental transcription factors (TFs), suggesting that TFs are the key factors for the pathogenesis of NSOFC subtypes. Interestingly, we observed an opposite effect of the genetic variants in the IRF6 gene for CPO and CLO. Moreover, the gene expression dosage effect of IRF6 with two different alleles at the same single-nucleotide polymorphism (SNP) plays important roles in driving CPO or CLO. In addition, PAX9 is a key TF for CPO. Our findings define subtypes of NSOFC using genetic factors and their functional ontologies and provide a clue to improve their diagnosis and treatment in the future.

945 Southern Han Chinese ancestry cases, 5,048 Southern Han Chinese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

12363
Total Participants
GWAS
Study Type
Yes
Replicated
1,273 Han Chinese ancestry cases, 5,097 Han Chinese ancestry controls
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.